246 related articles for article (PubMed ID: 24788656)
1. Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study.
van Hal SJ; Chen SC; Sorrell TC; Ellis DH; Slavin M; Marriott DM
J Antimicrob Chemother; 2014 Aug; 69(8):2210-4. PubMed ID: 24788656
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.
Fernández-Ruiz M; Guinea J; Lora-Pablos D; Zaragoza Ó; Puig-Asensio M; Almirante B; Cuenca-Estrella M; Aguado JM; ;
Clin Microbiol Infect; 2017 Sep; 23(9):672.e1-672.e11. PubMed ID: 28143788
[TBL] [Abstract][Full Text] [Related]
4. Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection.
Brosh-Nissimov T; Ben-Ami R
Clin Microbiol Infect; 2015 Nov; 21(11):1011-7. PubMed ID: 26183300
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility to fluconazole of clinical interest yeasts: new breakpoints].
García-Agudo L; García-Martos P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):266-8. PubMed ID: 23303258
[TBL] [Abstract][Full Text] [Related]
7. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.
Grim SA; Berger K; Teng C; Gupta S; Layden JE; Janda WM; Clark NM
J Antimicrob Chemother; 2012 Mar; 67(3):707-14. PubMed ID: 22184469
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
9. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints.
Gamaletsou MN; Daikos GL; Walsh TJ; Perlin DS; Ortigosa CJ; Psaroulaki A; Pagoni M; Argyropoulou A; Nepka M; Perivolioti E; Kotsopoulou M; Perloretzou S; Marangos M; Kofteridis D; Grammatikou M; Goukos D; Petrikkos G; Sipsas NV
Int J Antimicrob Agents; 2014 Sep; 44(3):248-55. PubMed ID: 25108876
[TBL] [Abstract][Full Text] [Related]
11. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
12. Antifungal resistance in patients with Candidaemia: a retrospective cohort study.
Aldardeer NF; Albar H; Al-Attas M; Eldali A; Qutub M; Hassanien A; Alraddadi B
BMC Infect Dis; 2020 Jan; 20(1):55. PubMed ID: 31952505
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.
Puig-Asensio M; Ruiz-Camps I; Fernández-Ruiz M; Aguado JM; Muñoz P; Valerio M; Delgado-Iribarren A; Merino P; Bereciartua E; Fortún J; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2015 May; 21(5):491.e1-10. PubMed ID: 25703212
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.
Chalmers C; Gaur S; Chew J; Wright T; Kumar A; Mathur S; Wan WY; Gould IM; Leanord A; Bal AM
Mycoses; 2011 Nov; 54(6):e795-800. PubMed ID: 21615542
[TBL] [Abstract][Full Text] [Related]
15. The association between treatment appropriateness according to EUCAST and CLSI breakpoints and mortality among patients with candidemia: a retrospective observational study.
Ghanem-Zoubi N; Zorbavel D; Khoury J; Geffen Y; Qasum M; Predescu S; Paul M
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2397-2404. PubMed ID: 30284179
[TBL] [Abstract][Full Text] [Related]
16. Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran.
Charsizadeh A; Mirhendi H; Nikmanesh B; Eshaghi H; Makimura K
Mycoses; 2018 Jan; 61(1):22-29. PubMed ID: 28872714
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of Sensititre YeastOne and Micronaut-AM EUCAST for antifungal susceptibility testing in candidaemia isolates.
Bélik F; Deckers C; Khourssaji M; Huang TD; Denis O; Montesinos I
J Mycol Med; 2024 Mar; 34(1):101465. PubMed ID: 38401236
[TBL] [Abstract][Full Text] [Related]
19. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.
Colombo AL; Garnica M; Aranha Camargo LF; Da Cunha CA; Bandeira AC; Borghi D; Campos T; Senna AL; Valias Didier ME; Dias VC; Nucci M
Med Mycol; 2013 Jan; 51(1):38-44. PubMed ID: 22762208
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility testing and candidaemia at a tertiary referral hospital.
O'Connell K; Lyons M; Hanahoe B; Cormican M
Ir Med J; 2011 Feb; 104(2):55-6. PubMed ID: 21465880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
